van der Geest, Patrick J <br/><br/>
Micafungin versus anidulafungin in critically ill patients with invasive candidiasis: a retrospective study.  [electronic resource] 

 -  BMC infectious diseases  09 2016 
 - 490 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1471-2334 
<br/><br/><label>Standard No.: </label>10.1186/s12879-016-1825-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>APACHE<br/>Anidulafungin<br/>Antifungal Agents--economics<br/>Candidiasis, Invasive--drug therapy<br/>Critical Illness<br/>Echinocandins--economics<br/>Female<br/>Humans<br/>Intensive Care Units<br/>Lipopeptides--economics<br/>Liver--drug effects<br/>Liver Function Tests<br/>Male<br/>Micafungin<br/>Middle Aged<br/>Regression Analysis<br/>Retrospective Studies<br/>Treatment Outcome